Replies to post #451415 on Anavex Life Sciences Corp (AVXL)

[sage4]

I got your point but Rett is rare disease and hard to recruit volunteers for the trial I assumed. I thought it's crucial for Dr. Missling to change the trial design for the success. Not the patients.